Monterey
Monterey
The bay where cold Pacific upwelling creates one of the most biologically active marine ecosystems on the coast. Where the water is cold and clear and full of life — a system that sustains itself through constant, diverse, coordinated activity.
Full-spectrum immune support. From a single culture.
The organism that launched the modern probiotic industry.
Rich and creamy. A clean, mild flavor. Our everyday classic.
Richer, with a deeper and more complex flavor. For those who want more from every jar.
Our richest and thickest. Cold-strained for maximum culture concentration.
Produced in a home kitchen under the Wyoming Food Freedom Act - not inspected by the state or a local health department. For informed consumers only.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
The culture that launched the modern probiotic industry.
In 1930, microbiologist Dr. Minoru Shirota isolated a culture of Lactobacillus casei at Kyoto University with the specific goal of developing a fermented milk product that could make the benefits of gut microbiology accessible to as many people as possible. Yakult — which he launched in 1935 — became one of the most widely consumed probiotic products in history. The culture he selected, L. casei Shirota, has since been the subject of hundreds of clinical trials. Monterey carries L. casei in the tradition Shirota established: patient fermentation for potency, not shelf life.
What distinguishes L. casei in the immune literature is the breadth of its immune activation. Most probiotic organisms primarily affect one immune compartment — barrier function, or sIgA production, or Treg development. L. casei activates both the innate immune system (natural killer cells, macrophages) and the adaptive immune system (B-cell antibody production, T-cell proliferation) simultaneously. This broad-spectrum immune engagement has made it one of the most studied organisms for immune support in the probiotic literature.
Particularly relevant is L. casei's documented effects on respiratory mucosal immunity — the sIgA coating the nasal passages, throat, and airways. Most gut probiotics' immune effects remain largely local to the gut. L. casei's effects on respiratory mucosal IgA represent a documented extension of gut immune stimulation into the compartment where most everyday infections begin. The mechanism explains what clinical trials have consistently documented: fewer respiratory illness episodes in people consuming L. casei regularly.
Minoru Shirota's guiding conviction was that gut health should not be a privilege. He priced Yakult to be affordable, distributed it door-to-door through networks of Yakult Ladies, and pursued markets in regions with poor sanitation where the benefits would be most significant. His L. casei culture has since been studied in over 100 clinical trials across immune function, digestive health, and infectious disease prevention. The culture in Monterey belongs to the same species — brought to the same conclusion by a different path: patient fermentation in Wheatland, Wyoming, for the people who live nearby.
The conditions that reduce the immune system's active response capacity.
The immune system does not decline uniformly with age or stress — it becomes dysregulated. NK cell activity decreases, antibody response slows, respiratory mucosal IgA production falls. The result is not a system that cannot respond, but one that responds more slowly, less precisely, and recovers more gradually. L. casei addresses this by stimulating the components of immune function most likely to be under-active.
Natural killer cell activity declines measurably with age — by the sixth and seventh decades, NK cytotoxicity may be a fraction of what it was at 30. Antibody response velocity also slows. L. casei's documented stimulation of NK cell activity is most relevant in older adults precisely because this is where the baseline has fallen furthest from what the immune system is capable of with appropriate support.
Sustained cortisol elevation suppresses NK cell activity through glucocorticoid receptor signaling on NK cells. Chronic psychological stress produces measurable NK cell functional decline within weeks. People under sustained high stress — caregivers, people in demanding professional roles, those going through significant life disruptions — are operating with reduced innate immune capacity at precisely the times when they are also most exposed to immune challenges.
Respiratory mucosal IgA — the antibody that lines the nasal passages and airways — is the first defense against inhaled pathogens. Its production fluctuates seasonally, with lower levels in winter correlating with higher respiratory infection rates. L. casei's documented stimulation of respiratory mucosal IgA provides a directly relevant mechanism for the seasonal pattern of increased vulnerability.
Intense exercise creates a 3 to 72 hour window of immune suppression — specifically depressed mucosal IgA and NK cell activity — following hard training. This is why athletes who train heavily get sick more than recreationally active people, despite being otherwise healthier. L. casei's sustained immune stimulation reduces the magnitude and duration of this post-exercise window through maintained antibody and NK cell activity.
Both arms of the immune system, simultaneously activated.
The immune system has two primary arms — innate (fast, non-specific, the first response) and adaptive (slow, specific, the long-term defense). L. casei activates both. Here is how.
The immune system's immediate defense — active within minutes to hours of encountering a pathogen. Does not require prior exposure or memory.
The immune system's precision defense — requires days to weeks but produces long-lasting, pathogen-specific protection through immunological memory.
Natural killer cells are the immune system's innate anti-viral and anti-tumor lymphocytes — they can identify and kill virus-infected cells and aberrant cells without requiring prior sensitization or the antigen presentation required by cytotoxic T cells. NK cytotoxicity declines with age, stress, and poor sleep in ways that are measurable in blood panels. L. casei stimulates NK cell activation through IL-12 and IFN-gamma production by gut dendritic cells responding to L. casei cell wall components. The result is increased NK cell cytotoxic activity — a faster and more effective first cellular response to viral infection. The Parra et al. trial and multiple follow-up studies have directly measured this NK activation in human subjects.
Secretory IgA at respiratory mucosal surfaces is the antibody that coats the lining of the nasal passages, throat, and airways. It binds inhaled pathogens before they can adhere to and infect epithelial cells — acting as a first-line antibody barrier that most viruses and bacteria must overcome before they can establish infection. L. casei stimulates respiratory mucosal IgA through the gut-associated lymphoid tissue (GALT), which communicates with mucosal immune sites throughout the body via secretory IgA-producing plasma cells that migrate from gut lymph nodes to respiratory mucosa through the systemic circulation. This gut-to-respiratory immune communication is documented and is the mechanism behind the clinical finding that gut probiotic supplementation reduces upper respiratory infections.
L. casei activates B cells through multiple pathways — direct TLR-2 stimulation, cytokine signaling from L. casei-primed dendritic cells, and T-cell help from L. casei-activated Th1 cells. The result is increased production of IgA, IgM, and IgG — the three primary antibody classes. IgA provides mucosal defense; IgM is the rapid early response antibody; IgG is the long-lasting systemic antibody that persists after infection. Elevated baseline antibody production means faster and more robust responses when the immune system encounters new challenges.
Daily L. casei use does not produce acute immune events — it maintains an elevated immune readiness baseline. The NK cell activity, mucosal IgA levels, and antibody production stimulated by L. casei are not spikes that occur in response to infection. They are a sustained elevation of the immune system's resting state — a higher floor from which the immune response launches when challenge arrives. The practical consequence is not that L. casei prevents specific infections, but that the immune system responds faster, clears infection more efficiently, and recovers more completely when challenges occur.
Published research. Read it yourself.
L. casei has one of the deepest immune function evidence bases in the probiotic literature, built across decades and multiple independent research groups. Four studies representative of the breadth.
Read the detail
A randomized, double-blind, placebo-controlled trial in 360 elderly subjects (over 60 years, institutionalized) consuming L. casei DN-114 001 fermented milk or control dairy for three months during winter. Primary outcomes were incidence, duration, and severity of common infectious diseases — particularly respiratory and gastrointestinal infections. Elderly populations have measurably compromised immune function, making them a particularly relevant test population for immune support interventions.
The L. casei group experienced significantly shorter duration of common infectious diseases — particularly respiratory infections — compared to the control group. Total number of days with at least one symptom was significantly reduced. The effect was most pronounced in subjects who had longer duration infections at baseline, consistent with L. casei's mechanism of improving immune response speed and efficiency rather than preventing infection entirely. The study became one of the most cited demonstrations of probiotic effects on respiratory illness in a human RCT.
Read the detail
A randomized crossover trial in healthy adults measuring NK cell cytotoxicity, lymphocyte proliferation, and antibody levels before and after L. casei supplementation. The crossover design — where each subject served as their own control — is particularly rigorous for controlling individual variation in baseline immune function. The study specifically measured NK cell activity rather than relying on infection incidence as a proxy.
L. casei supplementation produced statistically significant increases in NK cell cytotoxic activity compared to placebo periods, alongside increases in total lymphocyte counts and IgA levels. The NK cell activation was the largest magnitude immune change observed, consistent with L. casei's documented mechanism of IL-12-mediated NK stimulation. The study confirmed that L. casei's immune effects are not limited to sick or immunocompromised populations — healthy adults show measurable immune activation through the same pathways.
Read the detail
A clinical study examining L. casei Shirota's effects on NK cell activity in patients with autoimmune disorders and chronic fatigue syndrome — conditions associated with measurably deficient NK cell function. Researchers measured NK cytotoxicity and NK cell subset counts before and after supplementation, comparing responses in patients with low NK baseline versus healthy controls.
L. casei Shirota supplementation significantly improved NK cell activity in patients with low baseline NK function — the deficient populations showed the largest magnitude response, consistent with L. casei's mechanism being restorative rather than merely additive. Patients with the lowest baseline NK cytotoxicity saw the greatest improvements. The finding extended the NK cell activation evidence from healthy populations into clinically relevant patient groups where NK deficiency is both documented and consequential.
Read the detail
A longitudinal study in healthy adults measuring NK cell number and cytotoxic activity over a 12-week period of daily L. casei Shirota supplementation, with follow-up measurement after stopping supplementation. The study was designed to determine whether L. casei's NK cell effects were sustained during continuous daily use and whether they reversed after stopping — critical for understanding whether L. casei produces ongoing maintenance rather than a one-time boost.
Daily L. casei Shirota supplementation maintained NK cell count and cytotoxic activity at elevated levels throughout the 12-week study period. After stopping supplementation, NK cell activity declined back toward pre-supplementation levels over subsequent weeks — confirming that the NK maintenance required ongoing daily L. casei consumption and was not a permanent change. This dose-dependence on continuous use is consistent with L. casei's mechanism: it maintains an immune baseline that requires the organism's active presence, not a one-time correction.
Note: PubMed links use search queries rather than direct DOIs. Identify the correct paper by author, journal, and year. Vital Yogurts is not affiliated with any research institutions cited.
Honest about what to expect.
Monterey's effects are most visible in aggregate over months — fewer sick days, faster recovery when illness does occur, shorter duration of symptoms. These are not dramatic individual events. They are a pattern that emerges from a consistently better-supported immune baseline.
-
1
Fewer respiratory illness days over winter months
The Turchet trial documented shorter duration of respiratory infections rather than prevention. This is the more honest framing: Monterey does not prevent viral exposure. It means the immune system responds faster when exposure becomes infection, clears the pathogen more efficiently, and reaches recovery more quickly. People who track their sick days over a winter season with consistent Monterey use often notice the pattern — not no illness, but less of it when it happens.
-
2
Reduced severity during high-exposure periods
Travel, large gatherings, high-density workplaces, and seasonal transitions all increase pathogen exposure. People who use Monterey consistently describe getting through these periods with less consequence than before — not always avoiding illness, but experiencing less severe and shorter-duration episodes when they occur. This is the respiratory mucosal IgA and NK baseline maintenance working as designed: the immune response is available at a higher starting point when it needs to deploy.
-
3
The NK cell effect — ongoing, not one-time
The Morimoto longitudinal study confirmed that NK cell activity returns to baseline after stopping L. casei supplementation. This is important: the immune benefit requires continuous daily use, not a course of treatment followed by rest. Monterey is not an immune supplement to use when you feel something coming on. It is a daily culture whose value accumulates over months of consistent use and declines when the habit breaks. The daily ritual is the intervention.
-
4
Better immune resilience as you age
NK cell activity declines with age on a trajectory that is measurable and largely inevitable in the absence of deliberate support. Consistent Monterey use does not reverse this trajectory — but it slows it. The Shida study showed that NK cell restoration is greatest in the populations with the lowest baseline. Starting Monterey before significant NK decline occurs means maintaining a higher floor as the years progress. This is the most important reason to begin rather than wait.
Our Live Fermented Milks are genuinely potent. When you introduce a large number of live beneficial cultures into a microbiome that has grown quieter over time, your body notices. Some people feel temporary bloating or mild discomfort in the first hour or two after their first few servings. This is your body adjusting. It passes. Start with two to four ounces and pay attention to how you feel before adding more. The daily ritual builds over weeks, not hours.
Cultures that complement Monterey.
Monterey activates the active immune response. These three cultures add barrier protection, immune tolerance, and gut stability — covering the full spectrum of immune support from structure to activation to recovery.
Regulatory T-cell development and IL-10 production — the tolerance arm of immune function. Shenandoah ensures Monterey's activated immune response remains calibrated, not inflammatory.
Hudson Valley Lactobacillus acidophilusSecretory IgA induction and gut barrier integrity. Adds foundational mucosal protection beneath Monterey's active immune activation — the structure that makes the response more effective.
Finger Lakes Saccharomyces boulardiiAntibiotic-immune gut stability. When Monterey's bacterial populations are disrupted by antibiotics, Finger Lakes maintains the mucosal immune defense that bridges the gap until bacterial cultures recover.